Sartorius Aktiengesellschaft
Research Sartorius Aktiengesellschaft (0NIQ) on Bullrun: P/E 30.4, dividend yield 0.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0NIQ
- ExchangeLSE
- CountryGermany
- SectorTechnology
- IndustryScientific & Technical Instruments
- CurrencyEUR
- P/E30.4
- Dividend yield0.4%
- Financial periodQ1 2026
- RevenueEUR 899.10M
- Net incomeEUR 56.20M
- Free cash flowEUR 111.20M
- Gross margin46.1%
Valuation Snapshot
P/E is 30.4; dividend yield is 0.4%.
Peer valuation comparison
Latest P/E is 30.41x versus a Technology sector median of 28.57x (6.4% above).
Latest dividend yield is 0.36% versus a Technology sector median of 1.65% (78.2% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-26 | n/a | 30.4 | n/a | 0.74 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.74 EUR, yield 0.4%.
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems;
Related stock research
Other Technology stocks
Frequently asked questions
What is Sartorius Aktiengesellschaft's P/E ratio?
Sartorius Aktiengesellschaft's price-to-earnings (P/E) ratio is 30.4.
Does Sartorius Aktiengesellschaft pay a dividend?
Sartorius Aktiengesellschaft has a dividend yield of 0.4%.
What does Sartorius Aktiengesellschaft do?
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid.